Stericycle, Inc. (NASDAQ:SRCL) Shares Sold by Palmer Knight Co

Palmer Knight Co reduced its stake in shares of Stericycle, Inc. (NASDAQ:SRCL) by 11.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,628 shares of the business services provider’s stock after selling 1,000 shares during the quarter. Palmer Knight Co’s holdings in Stericycle were worth $378,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of SRCL. Ariel Investments LLC increased its stake in Stericycle by 5.7% in the third quarter. Ariel Investments LLC now owns 4,328,036 shares of the business services provider’s stock valued at $193,506,000 after purchasing an additional 233,612 shares during the period. Robeco Schweiz AG increased its stake in Stericycle by 17.6% in the third quarter. Robeco Schweiz AG now owns 1,019,692 shares of the business services provider’s stock valued at $45,590,000 after purchasing an additional 152,780 shares during the period. Impax Asset Management Group plc increased its stake in Stericycle by 4.9% in the fourth quarter. Impax Asset Management Group plc now owns 3,139,032 shares of the business services provider’s stock valued at $154,396,000 after purchasing an additional 147,452 shares during the period. Envestnet Asset Management Inc. increased its stake in Stericycle by 62.3% in the third quarter. Envestnet Asset Management Inc. now owns 329,971 shares of the business services provider’s stock valued at $14,753,000 after purchasing an additional 126,700 shares during the period. Finally, Earnest Partners LLC increased its stake in Stericycle by 6.6% in the third quarter. Earnest Partners LLC now owns 1,941,254 shares of the business services provider’s stock valued at $86,793,000 after purchasing an additional 120,852 shares during the period. 98.82% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SRCL has been the topic of several analyst reports. StockNews.com downgraded shares of Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, April 2nd. Truist Financial lowered their target price on shares of Stericycle from $57.00 to $50.00 and set a “hold” rating on the stock in a report on Monday. Robert W. Baird reduced their price target on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday. Wells Fargo & Company upped their price target on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a report on Friday, March 1st. Finally, Stifel Nicolaus boosted their price objective on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research report on Thursday, February 29th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $59.40.

Stericycle Stock Up 0.2 %

NASDAQ SRCL traded up $0.10 during trading hours on Monday, reaching $46.41. 212,736 shares of the company traded hands, compared to its average volume of 463,725. The stock has a market capitalization of $4.31 billion, a PE ratio of -211.95, a PEG ratio of 2.49 and a beta of 1.09. Stericycle, Inc. has a 12 month low of $37.78 and a 12 month high of $57.06. The company has a 50 day moving average of $51.35 and a two-hundred day moving average of $48.24. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The business had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. During the same quarter last year, the company earned $0.49 EPS. The company’s revenue for the quarter was down 2.8% compared to the same quarter last year. As a group, equities analysts expect that Stericycle, Inc. will post 2.32 earnings per share for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.